Novo Integrated Sciences, Inc. (NASDAQ:NVOS – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 297,600 shares, an increase of 79.5% from the March 31st total of 165,800 shares. Currently, 3.3% of the shares of the company are sold short. Based on an average daily volume of 66,500 shares, the days-to-cover ratio is presently 4.5 days.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Citadel Advisors LLC purchased a new stake in Novo Integrated Sciences during the second quarter valued at about $30,000. Millennium Management LLC purchased a new stake in shares of Novo Integrated Sciences in the second quarter worth about $111,000. Finally, Morgan Stanley purchased a new stake in shares of Novo Integrated Sciences in the second quarter worth about $288,000. 12.48% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ NVOS opened at $2.29 on Friday. The company has a market cap of $68.53 million, a PE ratio of -6.74 and a beta of -0.24. Novo Integrated Sciences has a 52 week low of $1.02 and a 52 week high of $3.32. The company has a quick ratio of 1.62, a current ratio of 1.65 and a debt-to-equity ratio of 0.24. The firm’s 50-day simple moving average is $2.14 and its two-hundred day simple moving average is $1.69.
Novo Integrated Sciences, Inc, together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.
- Get a free copy of the StockNews.com research report on Novo Integrated Sciences (NVOS)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- O’Reilly Automotive Hits A Pothole
Receive News & Ratings for Novo Integrated Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Integrated Sciences and related companies with MarketBeat.com's FREE daily email newsletter.